Skip to content

Neuropace, Inc. NPCE Inventory turnover

Inventory turnover at other companies

Medtronic logo
MedtronicMDT
2.2×+0.1×
LivaNova logo
LivaNovaLIVN
2.9×+0.3×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
3.5×-69.2×
Inspire Medical Systems logo
Inspire Medical SystemsINSP
-0.8×
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
1.4×0.0×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
3.1×-0.7×

Other financials

Income statement

See full
Revenue$22.1M-2.0%
Gross profit$18.0M+4.1%
Operating income-$5.6M-8.2%
Net income-$6.7M-1.5%
EPS (diluted)-$0.20+4.8%

Balance sheet

See full
Cash & equivalents$15.6M-42.4%
Total debt$70.5M-3.7%
Total equity$14.5M-40.4%
Total assets$98.9M-10.3%

Cash flow

See full
Operating cash flow-$5.9M+21.1%
CapEx$117.0K+216%
Free cash flow-$6.0M+20.0%

Valuation

See full
Market cap$557.77M+63.4%
Enterprise value$612.6M+58.1%
P/S5.6×+1.6×

Profitability

See full
Gross margin78.3%+3.5pp
Operating margin-16.8%-3.5pp
Net margin-21.7%-4.5pp
FCF margin-10.3%-3.5pp

Returns & leverage

See full
Return on equity-111.4%-13.1pp
Debt / equity4.9×+1.9×
Current ratio5.4×-1.2×

Where this comes from

Calculated from Neuropace, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s inventory turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuropace, Inc.'s inventory turnover?
Neuropace, Inc. (NPCE) reported inventory turnover of 1.4× in Q1 2026.
How has Neuropace, Inc.'s inventory turnover changed year-over-year?
Neuropace, Inc.'s inventory turnover decreased by 15.9% year-over-year, from 1.7× to 1.4×.
What is the long-term trend for Neuropace, Inc.'s inventory turnover?
Over 4 years (2021 to 2025), Neuropace, Inc.'s inventory turnover has grown at a -1.5% compound annual growth rate (CAGR), from 1.6× to 1.5×.
What does inventory turnover mean?
Trailing-twelve-month cost of revenue divided by average inventory. Measures how many times inventory is sold and replaced over the year.